Sex differences in the resistance of turkeys to Escherichia coli challenge after immunosuppression with dexamethasone.
Five-week-old male and female commercial turkeys were immunosuppressed with two levels of dexamethasone (DEX) and challenged by airsac inoculation with 100 cfu of Escherichia coli. Mortality and airsacculitis (AS) scores were significantly higher in challenged birds treated with DEX and marginally higher in males than in females. Male mortalities had significantly higher AS scores than females. Recovery of E. coli from blood and tissues was significantly higher in challenged birds treated with DEX, marginally higher in males (P = 0.09), and significantly higher in male mortalities than in female mortalities. The low level of DEX seemed to have a protective effect against bacterial challenge in males, whereas the high level of DEX had a more adverse effect in males than in females. Body weights 2 wk postchallenge were significantly decreased by both DEX and E. coli, challenge. Relative liver and heart weights were increased by both DEX and E. coli, challenge, whereas bursal:spleen ratios were decreased by both treatments. Total leukocyte counts and relative heterophil counts from blood samples taken 24 h postinfection were significantly higher in DEX-treated birds and in unchallenged DEX-treated females than in males. The DEX treatment resulted in significantly higher heterophil:lymphocyte ratios, but there was no difference between sexes. Males had significantly lower serum levels of uric acid, total protein, albumin, aspartate aminotransferase, and lactate dehydrogenase than did females. Dexamethasone treatment also resulted in lower levels of total protein, albumin, and aspartate aminotransferase. These data suggest that male turkeys may be more susceptible to colisepticemia than female turkeys, especially when under severe stress.